<DOC>
	<DOC>NCT02177370</DOC>
	<brief_summary>The aim of the study was to compare the effect of fenoterol metered dose inhaler with disodium cromoglycate (DSCG) metered dose inhaler on the lymphocyte β2-receptor population as well as on the clinical findings in patients with bronchial asthma over a two-week period of treatment.</brief_summary>
	<brief_title>Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fenoterol</mesh_term>
	<criteria>sex: male and female age: 18 years or over bronchial asthma, diagnosis confirmed by history and positive inhalation challenge test (unspecific challenge with carbachol, PD100SRaw)) severity of asthma mild to moderate or asthmatic in symptomfree intervals Raw ≤ 5 cm H2O/l/s no antiasthmatic treatment in the week (steroid therapy: two weeks) before the start of the study clinically significant, concomitant haematological, cardiac, renal, hepatic or metabolic diseases intercurrent diseases, e.g. severe respiratory infections patients who cannot do without the following preparations during the 5week trial: inhaled/oral steroids theophylline antihistamine, antiallergic drugs inhaled/oral sympathomimetics anticholinergics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>